Literature DB >> 15375326

Itch: more than skin deep.

Malcolm W Greaves1, Nedha Khalifa.   

Abstract

Recent research in neurophysiology of itch has indicated the existence of itch-dedicated nociceptor neurones. The perception of itch is regulated by tonically inhibitory descending neuronal pathways and nociceptor spinal neuronal circuits. There is at present no convincing evidence of an 'itch centre' in the brain. A classification of itch has been proposed, based on neurophysiological considerations, which stresses the importance of neurogenic and neuropathic itch, and assists in differential diagnosis and selection of treatment. However, more than one class of itch can occur concurrently in the same patient. The importance of cross- talk between dermal mast cells and nociceptor nerve terminals, involving cleavage of proteinase-activated receptor 2 by mast cell tryptase, is highlighted. The pruritus of cholestasis is mediated at least in part by opioid peptides synthesized by the liver, and elevated levels of these mediators are found in the plasma and skin of patients with itch due to cholestasis. The combined use of both mu-receptor antagonists and kappa-receptor agonists (anti-pruritic) is worth exploring.

Entities:  

Mesh:

Year:  2004        PMID: 15375326     DOI: 10.1159/000080898

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  18 in total

Review 1.  Basic mechanisms of itch.

Authors:  C Potenzieri; B J Undem
Journal:  Clin Exp Allergy       Date:  2011-06-06       Impact factor: 5.018

2.  Pathogenesis and treatment of pruritus.

Authors:  Malcolm W Greaves
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

3.  [Clinical features and prurigo nodularis in nephrogenic pruritus].

Authors:  T Böhme; T Heitkemper; T Mettang; N Q Phan; S Ständer
Journal:  Hautarzt       Date:  2014-08       Impact factor: 0.751

Review 4.  Frontiers in pruritus research: scratching the brain for more effective itch therapy.

Authors:  Ralf Paus; Martin Schmelz; Tamás Bíró; Martin Steinhoff
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

Review 5.  [Neurophysiology of atopic pruritus].

Authors:  N H Meyer; B Gibbs; M Schmelz; B Homey; U Raap
Journal:  Hautarzt       Date:  2018-03       Impact factor: 0.751

Review 6.  [Clinical classification of chronic pruritus. Interdisciplinary consensus proposal for a diagnostic algorithm].

Authors:  S Ständer; E Weisshaar; T Mettang; M Streit; U Darsow; G Schneider; D Metze; M Schmelz
Journal:  Hautarzt       Date:  2006-05       Impact factor: 0.751

Review 7.  Structures and biological functions of IL-31 and IL-31 receptors.

Authors:  Qing Zhang; Prabhakar Putheti; Qiang Zhou; Quansheng Liu; Wenda Gao
Journal:  Cytokine Growth Factor Rev       Date:  2008-10-15       Impact factor: 7.638

8.  Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice.

Authors:  K Kasutani; E Fujii; S Ohyama; H Adachi; M Hasegawa; H Kitamura; N Yamashita
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

9.  Mechanistic correlations between two itch biomarkers, cytokine interleukin-31 and neuropeptide β-endorphin, via STAT3/calcium axis in atopic dermatitis.

Authors:  C-H Lee; C-H Hong; W-T Yu; H-Y Chuang; S-K Huang; G-S Chen; T Yoshioka; M Sakata; W-T Liao; Y-C Ko; H-S Yu
Journal:  Br J Dermatol       Date:  2012-10       Impact factor: 9.302

10.  Barely scratching the surface.

Authors:  Aaron I Vinik
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.